Global Obesity Market (2023 Edition) – Analysis By Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs, Others), Age Group, By Gender, By Region, By Country: Drivers, Trends and Forecast to 2029
- USD
Licensing options
Category: Healthcare and Pharmaceutical
Publish Date: July 2023
No. of Pages: 270
Format: Pdf
Licensing options
Executive Summary
Azoth Analytics has released a research report titled “Global Obesity Market (2023 Edition)†which provides a complete analysis of the Global Obesity Industry By Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs, Other Drugs), Age Group (0-18 years, 19-39 years, 40-59 years, Above 60 years), Gender (Male, Female) for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East and Africa) and 10 countries (United States, Canada, Brazil, United Kingdom, Germany, France, Italy, Spain, China, Japan). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.
The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.
During the forecast period, 2024-2029, the Global Obesity Market is expected to expand at a CAGR of 14.4%. The rising population, as well as the limited awareness and education about the importance of healthy eating and physical activity, are driving the Global Obesity Market. The Global Obesity Market is expected to generate USD 61.7 billion by the end of 2029, up from USD 25.24 billion in 2022. Changing dietary habits, globalization and food availability, have emerged as key drivers for the global obesity market.
The global obesity epidemic has become one of the most pressing public health challenges of the 21st century. With increasing prevalence rates across all age groups and geographical regions, obesity has significant implications for individuals, healthcare systems, and societies at large. The research study delves into the complexities of the global obesity market, examining the drivers, restraints, and trends shaping the landscape. It also explores innovative solutions and strategies aimed at curbing obesity's rise and fostering a healthier future.
Changing dietary habits have a profound impact on the global obesity market. As people across the world adopt new eating patterns and food choices, the prevalence of obesity and overweight has been on the rise. It often involves the consumption of energy-dense, nutrient-poor foods that are high in calories, sugars, and unhealthy fats. These foods can lead to an energy imbalance, where individuals consume more calories than they expend, resulting in weight gain and obesity.
Changing dietary habits in the Asia Pacific region have had a significant impact on the prevalence of obesity and overweight, leading to an escalating obesity market in the region. As urbanization and globalization continue, traditional dietary practices are sometimes replaced by more convenient and processed food options. This shift can result in a decline in the consumption of nutrient-rich traditional foods, leading to nutritional imbalances.
Scope of the Report
• The report analyses the Global Obesity Market by Value (USD Billion).
• The report presents the analysis of the Global Obesity Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the Global Obesity Market by Gender (Male and Female).
• The report analyses the Global Obesity Market by Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs and Others).
• The report analyses the Global Obesity Market by Age Group (0 – 18 Years, 19 – 39 Years, 40 – 59 Years and Above 60 years).
• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Gender, by drug type and by age group.
• Also, the major opportunities, trends, drivers and challenges of the industry have been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Novo Nordisk, Eli Lilly and Company, Altimmune, Amgen, Carmot, Novartis, Zealand Pharma, AstraZeneca, Sciwind Biosciences and Bristol Myers Squibb.
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
2.1 Focus on Education & Awareness
2.2 Focus on Telemedicine & Digital Health Solutions
3. Global Obesity Market: Historic and Forecast (2019-2029)
3.1 Impact Analysis of Macro Economic Factors on the Obesity Market
3.2 Number of Deaths by Risk Factors Including Obesity, World, 2019
3.3 Prevalence of Adult Obesity
3.4 Global Percentage of Adults Facing Obesity as Biggest Health Problem, 2022
3.5 Biggest Health Problems among People Worldwide, 2022
3.6 Global Obesity Market: Dashboard
3.7 Global Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
3.8 Global Impact of COVID-19 on Obesity Market
3.9 Global Obesity Market Segmentation: By Gender
3.9.1 Global Obesity Market, By Gender Overview
3.9.2 Global Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
3.9.3 Global Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
3.10 Global Obesity Market Segmentation: By Drug Type
3.10.1 Global Obesity Market, By Drug Type Overview
3.10.2 Global Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
3.10.3 Global Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
3.10.4 Global Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
3.10.4 Global Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
3.11 Global Obesity Market Segmentation: By Age Group
3.11.1 Global Obesity Market, By Age Group Overview
3.11.2 Global Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
3.11.3 Global Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
3.11.4 Global Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
3.11.5 Global Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
4. Obesity Market, Regional Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Obesity Market: Historic and Forecast (2019-2029)
5.1 Americas Obesity Market: Snapshot
5.2 Americas Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.3 Americas Obesity Market: Key Factors
5.4 Americas Obesity Market Segmentation: By Gender
5.4.1 Americas Obesity Market, By Gender Overview
5.4.2 Americas Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.3 Americas Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
5.5 Americas Obesity Market Segmentation: By Drug Type
5.5.1 Americas Obesity Market, By Drug Type Overview
5.5.2 Americas Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.3 Americas Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.4 Americas Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.5 Americas Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
5.6 Americas Obesity Market Segmentation: By Age Group
5.6.1 Americas Obesity Market, By Age Group Overview
5.6.2 Americas Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
5.6.3 Americas Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
5.6.4 Americas Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
5.6.5 Americas Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
5.7 Americas Obesity Market Segmentation: By Country
5.7.1 United States Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.7.1.1 United States Obesity Market, By Gender
5.7.1.2 United States Obesity Market, By Drug Type
5.7.1.3 United States Obesity Market, By Age Group
5.7.2 Canada Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.7.2.1 Canada Obesity Market, By Gender
5.7.2.2 Canada Obesity Market, By Drug Type
5.7.2.3 Canada Obesity Market, By Age Group
5.7.3 Brazil Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.7.3.1 Brazil Obesity Market, By Gender
5.7.3.2 Brazil Obesity Market, By Drug Type
5.7.3.3 Brazil Obesity Market, By Age Group
5.7.4 Rest of Americas Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.7.4.1 Rest of Americas Obesity Market, By Gender
5.7.4.2 Rest of Americas Obesity Market, By Drug Type
5.7.4.3 Rest of Americas Obesity Market, By Age Group
6. Europe Obesity Market: Historic and Forecast (2019-2029)
6.1 Europe Obesity Market: Snapshot
6.2 Europe Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.3 Europe Obesity Market: Key Factors
6.4 Europe Obesity Market Segmentation: By Gender
6.4.1 Europe Obesity Market, By Gender Overview
6.4.2 Europe Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.3 Europe Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
6.5 Europe Obesity Market Segmentation: By Drug Type
6.5.1 Europe Obesity Market, By Drug Type Overview
6.5.2 Europe Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.3 Europe Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
6.6 Europe Obesity Market Segmentation: By Age Group
6.6.1 Europe Obesity Market, By Age Group Overview
6.6.2 Europe Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
6.6.3 Europe Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
6.6.4 Europe Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
6.6.5 Europe Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
6.7 Europe Obesity Market Segmentation: By Country
6.7.1 United Kingdom Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.1.1 United Kingdom Obesity Market, By Gender
6.7.1.2 United Kingdom Obesity Market, By Drug Type
6.7.1.3 United Kingdom Obesity Market, By Age Group
6.7.2 Germany Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.2.1 Germany Obesity Market, By Gender
6.7.2.2 Germany Obesity Market, By Drug Type
6.7.2.3 Germany Obesity Market, By Age Group
6.7.3 France Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.3.1 France Obesity Market, By Gender
6.7.3.2 France Obesity Market, By Drug Type
6.7.3.3 France Obesity Market, By Age Group
6.7.4 Italy Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.4.1 Italy Obesity Market, By Gender
6.7.4.2 Italy Obesity Market, By Drug Type
6.7.4.3 Italy Obesity Market, By Age Group
6.7.5 Spain Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.5.1 Spain Obesity Market, By Gender
6.7.5.2 Spain Obesity Market, By Drug Type
6.7.5.3 Spain Obesity Market, By Age Group
6.7.6 Rest of Europe Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.6.1 Rest of Europe Obesity Market, By Gender
6.7.6.2 Rest of Europe Obesity Market, By Drug Type
6.7.6.3 Rest of Europe Obesity Market, By Age Group
7. Asia Pacific Obesity Market: Historic and Forecast (2019-2029)
7.1 Asia Pacific Obesity Market: Snapshot
7.2 Asia Pacific Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.3 Asia Pacific Obesity Market: Key Factors
7.4 Asia Pacific Obesity Market Segmentation: By Gender
7.4.1 Asia Pacific Obesity Market, By Gender Overview
7.4.2 Asia Pacific Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.3 Asia Pacific Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
7.5 Asia Pacific Obesity Market Segmentation: By Drug Type
7.5.1 Asia Pacific Obesity Market, By Drug Type Overview
7.5.2 Asia Pacific Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.3 Asia Pacific Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.4 Asia Pacific Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.5 Asia Pacific Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
7.6 Asia Pacific Obesity Market Segmentation: By Age Group
7.6.1 Asia Pacific Obesity Market, By Age Group Overview
7.6.2 Asia Pacific Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
7.6.3 Asia Pacific Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
7.6.4 Asia Pacific Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
7.6.5 Asia Pacific Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
7.7 Asia Pacific Obesity Market Segmentation: By Country
7.7.1 China Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.7.1.1 China Obesity Market, By Gender
7.7.1.2 China Obesity Market, By Drug Type
7.7.1.3 China Obesity Market, By Age Group
7.7.2 Japan Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.7.2.1 Japan Obesity Market, By Gender
7.7.2.2 Japan Obesity Market, By Drug Type
7.7.2.3 Japan Obesity Market, By Age Group
7.7.3 Rest of APAC Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.7.3.1 Rest of APAC Obesity Market, By Gender
7.7.3.2 Rest of APAC Obesity Market, By Drug Type
7.7.3.3 Rest of APAC Obesity Market, By Age Group
8. Middle East & Africa Obesity Market: Historic and Forecast (2019-2029)
8.1 Middle East & Africa Obesity Market: Snapshot
8.2 Middle East & Africa Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
8.3 Middle East & Africa Obesity Market: Key Factors
8.4 Middle East & Africa Obesity Market Segmentation: By Gender
8.4.1 Middle East & Africa Obesity Market, By Gender Overview
8.4.2 Middle East & Africa Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.3 Middle East & Africa Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
8.5 Middle East & Africa Obesity Market Segmentation: By Drug Type
8.5.1 Middle East & Africa Obesity Market, By Drug Type Overview
8.5.2 Middle East & Africa Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.3 Middle East & Africa Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.4 Middle East & Africa Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.4 Middle East & Africa Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.1 Middle East & Africa Obesity Market, By Age Group Overview
8.6.2 Middle East & Africa Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.3 Middle East & Africa Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.4 Middle East & Africa Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.5 Middle East & Africa Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on the Obesity Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Macro-Economic Factor Assessment
10.2 Value Chain Analysis
10.3 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Obesity Market
11.4 Company Profiles
11.4.1 Novo Nordisk
11.4.2 Eli Lilly and Company
11.4.3 Altimmune
11.4.4 Amgen
11.4.5 Carmot
11.4.6 Novartis
11.4.7 Zealand Pharma
11.4.8 AstraZeneca
11.4.9 Sciwind Biosciences
11.4.10 Bristol Myers Squibb
List of Figures
Figure 1: Number of Deaths by Risk Factors including obesity, World, 2019 (in Millions)
Figure 2: Prevalence of adult Obesity(%)
Figure 3: Global Percentage of Adults Facing Obesity as Biggest Health Problem, by Country 2022
Figure 4: Global Percentage of Adults facing Biggest Health Problems in 2022
Figure 5: Global Obesity Market Size, By Value, 2019-2022 (USD Billion)
Figure 6: Global Obesity Market Size, By Value, 2024-2029 (USD Billion)
Figure 7: Global Obesity Market Share, By Gender, 2022 (%)
Figure 8: Global Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 9: Global Obesity Market Absolute Opportunity, By Male, 2019-2029 (USD Billion)
Figure 10: Global Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 11: Global Obesity Market Absolute Opportunity, By Female, 2019-2029 (USD Billion)
Figure 12: Global Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 13: Global Obesity Market Absolute Opportunity, By Appetite Suppressants, 2019-2029 (USD Billion)
Figure 14: Global Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 15: Global Obesity Market Absolute Opportunity, By Combination Drugs, 2019-2029 (USD Billion)
Figure 16: Global Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 17: Global Obesity Market Absolute Opportunity, By Malabsorption Drugs, 2019-2029 (USD Billion)
Figure 18: Global Obesity Market Size, By Other Drug Types, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 19: Global Obesity Market Absolute Opportunity, By Other Drug Types, 2019-2029 (USD Billion)
Figure 20: Global Obesity Market Size, By 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 21: Global Obesity Market Absolute Opportunity, By 0-18 Years, 2019-2029 (USD Billion)
Figure 22: Global Obesity Market Size, By 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 23: Global Obesity Market Absolute Opportunity, By 19-39 Years, 2019-2029 (USD Billion)
Figure 24: Global Obesity Market Size, By 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 25: Global Obesity Market Absolute Opportunity, By 40-59 Years, 2019-2029 (USD Billion)
Figure 26: Global Obesity Market Size, By Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 27: Global Obesity Market Absolute Opportunity, By Above 60 Years, 2019-2029 (USD Billion)
Figure 28: Americas Obesity Market Size, By Value, 2019H-2029F (USD Billion)
Figure 29: Americas Obesity Market Share, By Age Group, 2022 (%)
Figure 30: Americas Obesity Market, Male, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 31: Americas Obesity Market, Female, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 32: Americas Obesity Market, Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 33: Americas Obesity Market, Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 34: Americas Obesity Market, Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 35: Americas Obesity Market, Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 36: Americas Obesity Market, 0-18 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 37: Americas Obesity Market, 19-39 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 38: Americas Obesity Market, 40-59 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 39: Americas Obesity Market, Above 60 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 40: United States Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 41: United States Obesity Market Value, By Gender, 2022 (USD Billion)
Figure 42: United States Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 43: United States Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 44: United States Obesity Market Share, By Age Group, 2022 (%)
Figure 45: Canada Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 46: Canada Obesity Market Value, By Gender, 2022 (USD Billion)
Figure 47: Canada Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 48: Canada Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 49: Canada Obesity Market Share, By Age Group, 2022 (%)
Figure 50: Brazil Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 51: Brazil Obesity Market Value, By Gender, 2022 (USD Billion)
Figure 52: Brazil Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 53: Brazil Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 54: Brazil Obesity Market Share, By Age Group, 2022 (%)
Figure 55: Rest of Americas Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 56: Rest of Americas Obesity Market Value, By Gender, 2022 (USD Billion)
Figure 57: Rest of America Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 58: Rest of America Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 59: Rest of America Obesity Market Share, By Age Group, 2022 (%)
Figure 60: Europe Obesity Market Size, By Value, 2019H-2029F (USD Billion)
Figure 61: Europe Obesity Market Share, By Age Group, 2022 (%)
Figure 62: Europe Obesity Market, Male, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 63: Europe Obesity Market, Female, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 64: Europe Obesity Market, Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 65: Europe Obesity Market, Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 66: Europe Obesity Market, Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 67: Europe Obesity Market, Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 68: Europe Obesity Market, 0 - 18 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 69: Europe Obesity Market, 19 - 39 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 70: Europe Obesity Market, 40 - 59 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 71: Europe Obesity Market, Above 60 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 72: United Kingdom Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 73: United Kingdom Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 74: United Kingdom Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 75: United Kingdom Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 76: United Kingdom Obesity Market Share, By Age Group, 2022 (%)
Figure 77: Germany Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 78: Germany Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 79: Germany Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 80: Germany Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 81: Germany Obesity Market Share, By Age Group, 2022 (%)
Figure 82: France Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 83: France Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 84: France Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 85: France Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 86: France Obesity Market Share, By Age Group, 2022 (%)
Figure 87: Italy Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 88: Italy Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 89: Italy Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 90: Italy Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 91: Italy Obesity Market Share, By Age Group, 2022 (%)
Figure 92: Spain Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 93: Spain Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 94: Spain Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 95: Spain Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 96: Spain Obesity Market Share, By Age Group, 2022 (%)
Figure 97: Rest of Europe Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 98: Rest of Europe Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 99: Rest of Europe Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 100: Rest of Europe Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 101: Rest of Europe Obesity Market Share, By Age Group, 2022 (%)
Figure 102: Asia Pacific Obesity Market Size, By Value, 2019H-2029F (USD Billion)
Figure 103: Asia Pacific Obesity Market Share, By Age Group, 2022 (%)
Figure 104: Asia Pacific Obesity Market, Male, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 105: Asia Pacific Obesity Market, Female, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 106: Asia Pacific Obesity Market, Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 107: Asia Pacific Obesity Market, Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 108: Asia Pacific Obesity Market, Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 109: Asia Pacific Obesity Market, Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 110: Asia Pacific Obesity Market, 0 - 18 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 111: Asia Pacific Obesity Market, 19 - 39 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 112: Asia Pacific Obesity Market, 40 - 59 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 113: Asia Pacific Obesity Market, Above 60 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 114: China Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 115: China Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 116: China Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 117: China Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 118: China Obesity Market Share, By Age Group, 2022 (%)
Figure 119: Japan Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 120: Japan Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 121: Japan Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 122: Japan Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 123: Japan Obesity Market Share, By Age Group, 2022 (%)
Figure 124: Rest of Asia Pacific Obesity Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 125: Rest of Asia Pacific Obesity Market Value, By Drug Type, 2022 (USD Billion)
Figure 126: Rest of Asia Pacific Obesity Market Share, By Gender, By Value, 2022 (%)
Figure 127: Rest of Asia Pacific Obesity Market Share, By Drug Type, By Value, 2022 (%)
Figure 128: Rest of Asia Pacific Obesity Market Share, By Age Group, 2022 (%)
Figure 129: Middle East and Africa Obesity Market Size, By Value, 2019H-2029F (USD Billion)
Figure 130: Middle East and Africa Obesity Market Share, By Gender, 2022 (%)
Figure 131: Middle East and Africa Obesity Market, Male, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 132: Middle East and Africa Obesity Market, Female, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 133: Middle East & Africa Obesity Market, Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 134: Middle East & Africa Obesity Market, Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 135: Middle East & Africa Obesity Market, Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 136: Middle East & Africa Obesity Market, Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 137: Middle East & Africa Obesity Market, 0 - 18 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 138: Middle East & Africa Obesity Market, 19 - 39 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 139: Middle East & Africa Obesity Market, 40 - 59 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 140: Middle East & Africa Obesity Market, Above 60 years, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 141: Global Impact of Drivers and Restraints
Figure 142: Market Share of Prominent Companies in Global Obesity Market, 2022 (%)
Figure 143: Novo Nordisk Revenues, 2020-2022 (USD Million)
Figure 144: Novo Nordisk Revenues, By Geographic Segments, 2022 (%)
Figure 145: Novo Nordisk Revenues, By Business Segments, 2022 (%)
Figure 146: Eli Lilly and Company Revenues, 2020-2022 (USD Million)
Figure 147: Eli Lilly and Company Revenues, By Geographic Segments, 2022 (%)
Figure 148: Eli Lilly and Company Revenues, By Business Segments, 2022 (%)
Figure 149: Altimmune Revenues, 2020-2022 (USD Million)
Figure 150: Amgen Revenues, 2020-2022 (USD Million)
Figure 151: Novartis Revenues, 2020-2022 (USD Million)
Figure 152: Novartis Revenues, By Business Segments, 2022 (%)
Figure 153: Novartis Revenues, By Business Segments, 2021 (%)
Figure 154: Zealand Pharma Revenues, 2020-2022 (USD Million)
Figure 155: Zealand Pharma Revenues, By Geographic Segments, 2022 (%)
Figure 156: Zealand Pharma Revenues, By Geographic Segments, 2021 (%)
Figure 157: AstraZeneca Revenues, 2020-2022 (USD Million)
Figure 158: AstraZeneca Revenues, By Geographic Segments, 2022 (%)
Figure 159: AstraZeneca Revenues, By Geographic Segments, 2021 (%)
Figure 160: Bristol Myers Squibb Revenues, 2020-2022 (USD Million)
Figure 161: Bristol Myers Squibb Revenues, By Business Segments, 2022 (%)
Figure 162: Bristol Myers Squibb Revenues, By Business Segments, 2021 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A3: United States Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A4: United States Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A5: United States Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A6: United States Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A7: United States Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A8: Canada Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A9: Canada Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A10: Canada Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A11: Canada Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A12: Canada Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A13: Canada Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A14: Brazil Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A15: Brazil Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A16: Brazil Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A17: Brazil Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A18: Brazil Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A19: Brazil Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A20: Rest of Americas Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A21: Rest of Americas Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A22: Rest of Americas Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A23: Rest of Americas Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A24: Rest of Americas Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A25: Rest of Americas Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A26: United Kingdom Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A27: United Kingdom Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A28: United Kingdom Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A29: United Kingdom Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A30: United Kingdom Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A31: United Kingdom Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A32: Germany Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A33: Germany Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A34: Germany Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A35: Germany Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A36: Germany Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A37: Germany Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A38: France Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A39: France Obesity Market, By Gender, By Value, 2024-2029(USD Million)
Table A40: France Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A41: France Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A42: France Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A43: France Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A44: Italy Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A45: Italy Obesity Market, By Gender, By Value, 2024-2029(USD Million)
Table A46: Italy Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A47: Italy Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A48: Italy Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A49: Italy Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A50: Spain Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A51: Spain Obesity Market, By Gender, By Value, 2024-2029(USD Million)
Table A52: Spain Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A53: Spain Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A54: Spain Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A55: Spain Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A56: Rest of Europe Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A57: Rest of Europe Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A58: Rest of Europe Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A59: Rest of Europe Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A60: Rest of Europe Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A61: Rest of Europe Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A62: China Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A63: China Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A64: China Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A65: China Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A66: China Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A67: China Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A68: Japan Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A69: Japan Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A70: Japan Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A71: Japan Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A72: Japan Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A73: Japan Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A74: Rest of Asia Pacific Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A75: Rest of Asia Pacific Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A76: Rest of Asia Pacific Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A77: Rest of Asia Pacific Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A78: Rest of Asia Pacific Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A79: Rest of Asia Pacific Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A80: Novo Nordisk Key Financials, 2020-2022
Table A81: Eli Lilly and Company Key Financials, 2020-2022
Table A82: Altimmune Revenues, 2020-2022 (USD Million)
Table A83: Amgen Revenues, 2020-2022 (USD Million)
Table A84: Novartis Key Financials, 2020-2022
Table A85: Zealand Pharma Key Financials, 2020-2022
Table A86: AstraZeneca Key Financials, 2020-2022
Table A87: Bristol Myers Squibb Key Financials, 2020-2022
.jpg)
Global Medical Device Regulatory Affairs Market (2024 Edition): Analysis By Type ...
Read More.jpg)
Global Infectious Disease In vitro Diagnostics Market (2024 Edition): Analysis B ...
Read More
Global Medical Tourism Market (2024 Edition): Analysis By Service Provider (Publ ...
Read More.jpg)
Global Oxygen Cylinders and Concentrators Market (2024 Edition): Analysis By Pro ...
Read More.jpg)
Global Fertility Services Market (2024 Edition): Analysis By Gender (Male, Femal ...
Read More.jpg)
Global Irritable Bowel Disease Market (2024 Edition): Analysis By Drug Class (Co ...
Read More.jpg)
Global Immune Thrombocytopenia Drug Market (2024 Edition): Analysis By Treatment ...
Read More.jpg)
Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): An ...
Read MoreNo matter the hour, we’re here to help.
Contact us now!.jpg){kind=logo}
Azoth Analytics (ISO 9001:2015) is a business research and analytics company that creates in-depth research reports and provides customized research solutions and consulting services.
© 2024 Azoth Analytics | All rights reserved